Abstract
Many human cancers have a genetic component in their aetiology. In recent years, many specific genetic defects involved in cancer causation have been described. However, most remain to be discovered. The majority of known cancer genes have not yet been sufficiently characterized to be able to define their role in the multistage process of carcinogenesis. In order to both identify new cancer genes and to better define the function of known cancer genes, the use of appropriate model systems is crucial. While cell culture models are of value in this process, few exist in which the multistage process of carcinogenesis in specific tissues can be fully characterized. Thus, much attention is currently focused on developing rodent models of human cancer.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Burek JD, Hollander CV. Incidence patterns of spontaneous tumors in BN/Bi rats. J Natl Cancer Inst. 1977; 58: 99–105.
Sass B, Rabstein LS, Madison R, Nims RM, Peters RL, Kelloff GJ. Incidence of spontaneous neoplasms in F344 rats throughout the natural life-span. J Natl Cancer Inst. 1975; 54: 1449–1456.
Davis RK, Stevenson GT, Busch KA. Tumor incidence in normal Sprague-Dawley female rats. J Natl Cancer Inst. 1955; 15: 194–197.
Thompson SW, Huseby RA, Fox MA, Davis CL, Hunt RD. Spontaneous tumors in the Sprague-Dawley rat. J Natl Cancer Inst. 1961; 27: 1037–1057.
Maekawa A, Odashima S. Spontaneous tumors in ACI/N rats. J Natl Cancer Inst. 1975; 55: 1437–1445.
Dunning WF, Curtis MR. The respective roles of longevity and genetic specificity in the occurrence of spontaneous tumors in the hybrids between two inbred lines of rats. Cancer Res. 1945; 5: 62–81.
Crain RC. Spontaneous tumors in the Rochester strain of the Wistar rat. Am J Pathol. 1958; 34: 311–323.
Gould MN, Wang B, Moore CJ. Modulation of mammary carcinogenesis by enhancer and suppressor genes. In: Colburn NJ, ed. Genes and signal transduction in multistage carcinogenesis. New York: Marcel Decker, Inc.; 1989: 19–38.
Chen B, Johanson L, Wiest JS, Anderson MW, You M. The second intron of the K-ras gene contains regulatory elements associated with mouse lung tumor susceptibility. Proc Natl Acad Sci USA. 1994; 91(4): 1589–1593.
Yeung RS, Buetow KH, Testa JR, Knudson AG Jr. Susceptibility to renal carcinoma in the Eker rat involves a tumor suppressor gene on chromosome 10. Proc Natl Acad Sci USA. 1993; 90(17): 8038–8042.
Buchmann A, Bauer-Hofmann R, Mahr J, Drinkwater NR, Luz A, Schwarz M. Mutational activation of the c-Ha-ras gene in liver tumors of different rodent strains: Correlation with susceptibility to hepatocarcinogenesis. Proc Natl Acad Sci USA. 1991; 88(3): 911–915.
Wiklund J, Rutledge J, Gorski J. A genetic model for the inheritance of pituitary tumor susceptibility in F344 rats. Endocrinology. 1981; 109: 1708–1714.
Medina D. Mammary tumors. In: Foster JH, Small JD, Fox JG, eds. The mouse in biomedical research, Vol 4. New York: Academic Press; 1982: 373–396.
Dunning WF, Curtis MR, Segaloff A. Strain differences in response to diethylstilbestrol and the induction of mammary gland and bladder cancer in the rat. Cancer Res. 1947; 7: 511–521.
Haag JD, Newton MA, Gould MN. Mammary carcinoma suppressor and susceptibility genes in the Wistar-Kyoto rat. Carcinogenesis. 1992; 13(10): 1933–1935.
Gould MN. Inheritance and site of expression of genes controlling susceptibility to mammary cancer in an inbred rat model. Cancer Res. 1986; 46: 1199–1202.
Isaacs JT. Genetic control of resistance to chemically induced mammary adenocarcinogenesis in the rat. Cancer Res. 1986; 46: 3958–3963.
Dietrich WF, Miller JC, Steen FG et al. A genetic map of the mouse with 4,006 simple sequence high polymorphisms. Nature Genet. 1994; 7 Suppl:220–245.
Serikawa T, Kuramoto T, Hilbert P et al. Rat gene mapping using PCR-analyzed microsatellites. Genetics. 1992; 131: 701–721.
Hsu L-C, Kennan WS, Shepel L et al. Genetic identification of Mcs-1, a rat mammary carcinoma suppressor gene. Cancer Res. 1994; 54: 2765–2770.
Jacoby R, Hohman, Marshall et al. The use of microsatellite markers to map colon susceptibility genes in the mouse. Genomics. 1994; 22: 381–387.
Moser AR, Pitot HC, Dover WF. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science. 1990; 247: 322–341.
Su LK, Kinzler KW, Vogelstein B et al. A germline mutation of murine homolog of the APC gene causes multiple intestinal neoplasia. Science. 1992; 256: 668–670.
Moser AR, Dove WF, Roth KA, Gordon JI. The Min (multiple intestinal neoplasia) mutation: its effect on gut epithelial cell differentiation and interaction with a modifier system. J Cell Biol. 1992; 116: 1517–1526.
Dietrich WF, Lander ES, Smith JS et al. Genetic identification of Mom-1, a major modifier locus affecting min-induced intestinal neoplasia in the mouse. Cell. 1993; 75: 631–639.
Moser AR, Mattes EM, Dove WF, Lindstrom MJ, Haag JD, Gould MN. Min, a mutation in the murine Ape gene, predisposes to mammary carcinomas and focal alveolar hyperplasias. Proc Natl Acad Sci USA. 1993; 90: 8977–8981.
Fowlis DJ, Baimain A. Oncogenes and tumour suppressor genes in transgenic mouse models of neoplasia. Eur J Cancer. 1993; 29(4): 638–645.
Bailleul B, Surani MA, White S et al. Skin hyperkeratosis and papilloma formation in transgenic mice expressing a ras oncogene from a suprabasal keratin promoter. Cell. 1990; 62: 697–708.
Chisari FV, Klopchin K, Moriyama T et al. Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell. 1989; 59: 1145–1156.
Hanahan D. Heritable formation of pancreatic β-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes. Nature. 1991; 315: 115–122.
Sinn E, Muller W, Pattengale P, Tepler I, Wallace R, Leder P. Co-expression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice. Synergistic action of oncogenes in vivo. Cell. 1987; 49: 465–475.
Langdon WY, Harris AW, Cory S. Acceleration of B-lymphoid tumorigenesis in Eμ-myc transgenic mice by v-H-ras and v-raf but not v-abl. Oncogene Res. 1989; 4: 253–258.
Muller WJ, Sinn E, Pattengale PK, Wallace R, Leder P. Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell. 1988; 54: 105–115.
Bouchard L, Lamarre L, Tremblay PJ, Jolicoeur P. Stochastic appearance of mammary tumors in transgenic mice carrying the MMTV/c-neu oncogene. Cell. 1989; 57: 931–936.
Wang B, Kennan WS, Yasukawa-Barnes J, Lindstrom MJ, Gould MN. Carcinoma induction following direct in situ transfer of v-Ha-ras into rat mammary epithelial cells using replication-defective retrovirus vectors. Cancer Res. 1991; 51: 2642–2648.
Wang B, Kennan WS, Yasukawa-Barnes J, Lindstrom MJ, Gould MN. Frequent induction of mammary carcinomas following neu oncogene transfer into in situ mammary epithelial cells of susceptible and resistant strains of rats. Cancer Res. 1991; 51: 5649–5654.
Langdon WY, Harris AW, Cory S. Acceleration of B-lymphoid tumorigenesis in Eμ-myc transgenic mice by v-H-ras and v-ra/but not v-abl. Oncogene Res. 1989; 4: 253–258.
Capecchi MR. The new mouse genetics: Altering the genome by gene targeting. Trends Genet. 1989; 5: 70–76.
Gu H, Marth JD, Orban PC, Mossmann H, Rajewsky K. Deletion of a DNA polymerase β gene segment in T cells using cell type-specific gene targeting. Science. 1994; 265: 103–106.
Donehower LA, Harvey M, Slagle BL et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature. 1992; 356: 215–221.
Harvey M, McArthur MJ, Montgomery CA Jr, Bradley A, Donehower LA. Genetic background alters the spectrum of tumors that develop in p53-deficient mice. FASEB J. 1993; 7(10): 938–943.
Kemp CJ, Donehower LA, Bradley A, Balmain A. Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors. Cell. 1993; 74(5): 813–822.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Gould, M.N. (1995). Animal models for the study of genetic susceptibility to cancer. In: Ponder, B.A.J., Waring, M.J. (eds) The Genetics of Cancer. Cancer Biology and Medicine, vol 4. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-0677-1_6
Download citation
DOI: https://doi.org/10.1007/978-94-011-0677-1_6
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-4294-9
Online ISBN: 978-94-011-0677-1
eBook Packages: Springer Book Archive